Real-life experience with high-frequency chest wall oscillation vest therapy in adults with non-cystic fibrosis bronchiectasis.
Tara Lynn BartoDiego Jose MaselliSarah DaignaultJohn StiglichJared PorterCarlye KraemerGary HansenPublished in: Therapeutic advances in respiratory disease (2021)
NCFB patients showed improved self-reported outcomes associated with the initiation of HFCWO therapy as measured by number of hospitalizations, antibiotic use, and the subjective experience of airway clearance. The improvement was observed early on after initiation of therapy and sustained for at least 1 year. The reviews of this paper are available via the supplemental material section.
Keyphrases
- high frequency
- cystic fibrosis
- transcranial magnetic stimulation
- newly diagnosed
- ejection fraction
- pseudomonas aeruginosa
- prognostic factors
- randomized controlled trial
- systematic review
- depressive symptoms
- metabolic syndrome
- physical activity
- adipose tissue
- chronic kidney disease
- chronic obstructive pulmonary disease
- patient reported outcomes
- cell therapy
- bone marrow
- glycemic control